Emcure Pharmaceuticals Limited has informed the Exchange regarding 'Intimation under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Receipt of requests for re-classification from the Promoter and Promoter Group category to Public category'.
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts less than Nifty Smallcap 250 and 0.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Emcure Pharmaceuticals has informed the stock exchanges that 29 members of its promoter and promoter group have requested to be reclassified as public shareholders under SEBI's Regulation 31A. Importantly, none of these 29 individuals or entities currently hold any equity shares in the company. They include individuals like Jashvantlal H. Shah, Pravina Shah, Jigar Shah, Manish Shah, Madan Mohan Thapar, Ramni Thapar, Bhavna Battu, and entities such as several trusts, LLCs, and private limited companies. Each applicant has confirmed they have no board representation, are not key managerial personnel, and have no control or influence over the company's business or policy decisions. The board of directors will consider these requests in due course and seek necessary stock exchange approvals.
Since none of the 29 applicants hold any shares in the company, this reclassification does not change the actual shareholding pattern or promoter stake. It is a procedural cleanup of the promoter group list and is unlikely to have any material impact on the stock price or shareholder value.